CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth



Summary

The CD200R1-CD200 checkpoint, a critical immune regulator, inhibits macrophage phagocytosis of tumor cells through a distinct mechanism compared to the well-known SIRPα-CD47 interaction. While both checkpoints suppress tumor growth by preventing macrophage-mediated clearance, they engage different downstream signaling pathways within macrophages. CD200R1-CD200 signaling appears to rely more on SHP-1/2 recruitment and downstream signaling cascades, unlike SIRPα-CD47. This difference suggests that targeting the CD200R1-CD200 pathway could offer a novel strategy to enhance anti-tumor immunity, potentially circumventing resistance mechanisms developed against SIRPα-CD47 blockade.

Read more…

This post is part of “Science/Immunology News”, Follow for more…!!!